T. Rowe Price Investment Management, Inc.
Position in PSNL — Personalis, Inc.
CIK 1897612
BALTIMORE, MD
Position in PSNL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$30,309,039
+$14,882,265 QoQ
Shares Held
4,758,091
+145.5% QoQ
Ownership
4.46%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PSNL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026T. Rowe Price Investment Management, Inc. holds $7,246,348,599 across 15 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVTY |
Revvity, Inc.
|
18,261,177 | $2,031,738,553 | |
| 2 | WAT |
Waters Corp /De/
|
3,817,779 | $1,431,819,836 | |
| 3 | DHR |
Danaher Corp /De/
|
6,919,744 | $1,318,072,837 | |
| 4 | A |
Agilent Technologies, Inc.
|
7,756,921 | $1,030,351,816 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
694,424 | $887,133,604 | |
| 6 | NTRA |
Natera, Inc.
|
1,123,741 | $305,039,494 | |
| 7 | SHC |
Sotera Health Co
|
10,518,373 | $186,701,120 | |
| 8 | NEO |
Neogenomics Inc
|
1,216,358 | $17,746,663 |
All Filings in PSNL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,309,039 | 4,758,091 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,426,774 | 1,938,037 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $18,800,915 | 2,883,576 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,294,824 | 1,264,455 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||